Biogen (BIIB) Misses Q1 EPS by 76c, Announces CEO Transition
Tweet
Share
E-mail
Get Alerts BIIB Hot Sheet
Price: $216.94 -0.1%
EPS Growth %: -57.8%
Financial Fact:
Amortization of acquired intangible assets: 99.7M
Today's EPS Names:
OCCI, VIVO, PMCB, More
EPS Growth %: -57.8%
Financial Fact:
Amortization of acquired intangible assets: 99.7M
Today's EPS Names:
OCCI, VIVO, PMCB, More
Join SI Premium – FREE
Biogen (NASDAQ: BIIB) reported Q1 EPS of $3.62, $0.76 worse than the analyst estimate of $4.38. Revenue for the quarter came in at $2.53 billion versus the consensus estimate of $2.5 billion.
- Announces CEO Transition
- Reaffirms FY Guidance
For earnings history and earnings-related data on Biogen (BIIB) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Pinterest builds new AI layer with Nvidia using Blackwell GPUs
- FDA approves Biofrontera's Ameluz for superficial basal cell carcinoma
- Netflix shares climb on Evercore bumps price target
Create E-mail Alert Related Categories
Corporate News, Earnings, Hot Corp. News, Hot Earnings, Hot Mgmt Changes, Management ChangesRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
